Skip to content

Recordati Rare Diseases

Recordati Rare Diseases is the dedicated rare-disease business unit of the Recordati Group, focused on providing urgently needed medicines for rare and devastating diseases.

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Recordati Rare Diseases is a dedicated business unit focused on rare diseases within the Recordati Group. Since 2007 it has focused on helping the few who suffer from little known conditions, with a mission to reduce the impact of rare and devastating diseases by providing urgently needed medicines in key therapeutic areas. Its core therapy areas include endocrinology, oncology-hematology and metabolic. It works alongside global networks of patients, patient groups, experts, healthcare professionals, scientists, policy makers and regulators, and develops clinical trials for orphan drugs and in specialist regulatory requirements.

History

Recordati Rare Diseases is a dedicated business unit focused on rare diseases within the Recordati Group, which has delivered life enhancing and life changing medicines for 100 years. Since 2007, Recordati Rare Diseases has focused on helping the few who suffer from little known conditions. The wider Recordati group traces its origins to the 19th century, when the Recordati family began a small pharmacy in Correggio, Northern Italy. In 1926, Giovanni Recordati founded the company "Laboratorio Farmacologico Reggiano" at 28 years old. One hundred years later, in 2026, Recordati stands as a global pharmaceutical group with a presence in over 150 countries.

Products and positioning

Dedicated rare-disease business unit of the Recordati Group, focused on orphan and ultra-orphan diseases.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/recordati-rare-diseases · Editorial policy · How profiles are compiled